Research in Social and Administrative Pharmacy
Volume 6, Issue 3 , Pages 232-245 , September 2010

Factors related to pharmacists' care of migraineurs

  • Shane P. Desselle, R.Ph., Ph.D., FAPhA

      Affiliations

    • Department of Pharmacy, Clinical and Administrative Sciences, University of Oklahoma Health Sciences Center, College of Pharmacy, 4502 East 41st Street, Tulsa, OK 74137, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 918 660 3575; fax: +1 918 660 3009.
    • ,
  • Monica L. Skomo, Pharm.D.

      Affiliations

    • Duquesne University School of Pharmacy, Department of Pharmacy Practice, Pittsburgh, PA 15282, USA

References 

  1. Lipton RB, Stewart W, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41:646–657
  2. Ruiz de Velasco I, Gonzalez N, Etxeberria Y, Garcia-Monco JC. Quality of life in migraine patients: a qualitative study. Cephalalgia. 2003;23:892–900
  3. Kryst S, Scherl E. A population-based survey of the social and personal impact of headache. Headache. 1994;34:344–350
  4. Brandes J. Global trends in migraine care: results from the MAZE survey. CNS Drugs. 2002;16(suppl 1):13–18
  5. Lipton RB, Stewart W, Simon D. Medical consultation for migraine: results from the American Migraine Study. Headache. 1998;38:87–96
  6. Lipton RB, Diamond S, Reed M, Diamond M, Stewart W. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache. 2001;41:638–645
  7. Schreiber C, Hutchinson S, Webster C, Ames M, Richardson M, Powers C. Prevalence of migraine in patients with a history of self-reported or physician-diagnosed “sinus” headache. Arch Intern Med. 2004;164:1769–1772
  8. Diamond M. The role of concomitant headache types and non-headache co-morbidities in the underdiagnosis of migraine. Neurology. 2002;58(suppl 6):S3–S9
  9. Peters M, Huijer Abu-Saad H, Vydelingum V, Dowson A, Murphy M. Migraine and chronic daily headache management: a qualitative study of patients' perceptions. Scand J Caring Sci. 2004;18:294–303
  10. MacGregor EA, Brandes J, Eikermann A. Migraine prevalence and treatment patterns: the global migraine and zolmitriptan evaluation survey. Headache. 2003;43:19–26
  11. MacGregor EA, Brandes J, Gendolla A, Giammarco R. Migraine treatment strategies: the global Migraine and Zolmitriptan Evaluation (MAZE) survey—phase IV. Curr Med Res Opin. 2004;20:1777–1783
  12. Lipton RB, Stewart WF, Stone AM, Lainez MJ, Sawyer JP. The Disability in Strategies of Care (DISC) study. JAMA. 2000;284:2599–2605
  13. OTC products: 2004 survey of pharmacist recommendations. Pharm Times. 2004;(suppl):1–44
  14. Wenzel R, Lipton R, Diamond M, Cady R. Migraine therapy: a survey of pharmacists' knowledge, attitudes, and practice patterns. Headache. 2005;45:47–52
  15. Skomo ML, Desselle SP, Shah N. Development and construct validation of the pharmacists' care of migraineurs scale. Headache. 2009;49:54–63
  16. Liu Y, Doucette WR, Farris KB. Perceived difficulty and self-efficacy in the factor structure of perceived behavioral control to seek drug information from physicians and pharmacists. Res Social Adm Pharm. 2007;3:145–159
  17. Herbert KE, Urmie JM, Newland BA, Farris KB. Prediction of pharmacist intention to provide Medicare medication therapy management services using the theory of planned behavior. Res Social Adm Pharm. 2006;2:299–314
  18. Farris KB, Schopflocher DP. Between intention and behavior: an application of community pharmacists' assessment of pharmaceutical care. Soc Sci Med. 1999;49:55–66
  19. Coleman CL. Examining influences of pharmacists' communication with consumers about antibiotics. Health Commun. 2003;15:79–99
  20. Odedina FT, Hepler CD, Segal R, Miller D. The pharmacists' implementation of pharmaceutical care (PIPC) model. Pharm Res. 1997;14:135–144
  21. Clark BE, Mount JK. Pharmacy service orientation: a measure of organizational culture in pharmacy practice sites. Res Social Adm Pharm. 2006;2:110–128
  22. Fjortoft N. Identifying caring behaviors of pharmacists through observations and interviews. J Am Pharm Assoc. 2006;46:582–599
  23. Fjortoft N, Zgarrick DP. An assessment of pharmacists' caring ability. J Am Pharm Assoc. 2003;43:483–487
  24. Doucette WR, Nevins R, McDonough JP. Factors affecting collaborative care between physicians and pharmacists. Res Social Adm Pharm. 2005;1:565–578
  25. John OP. The “Big Five” factor taxonomy: dimensions of personality in the natural language and in questionnaires. In:  Pervin LA editors. Handbook of Personality: Theory and Research. 2nd ed.. New York: Guilford Press; 1999;p. 102–138
  26. Odedina FT, Segal R, Hepler CD, Lipowski E, Kimberlin C. Changing pharmacists' practice patterns: pharmacists' implementation of pharmaceutical care factors. J Soc Adm Pharm. 1996;13:74–88
  27. Berger BA, Grimley D. Pharmacists' readiness for rendering pharmaceutical care. J Am Pharm Assoc. 1997;NS37:535–542
  28. Miller MJ, Ortmeier BG. Factors influencing the delivery of pharmacists' services. Am Pharm. 1995;NS35:39–45
  29. Bandura A. Social Foundations of Thought and Action: A Social Cognitive Theory. Englewood Cliffs, NJ: Prentice-Hall; 1982;
  30. Skomo ML, Desselle SP, Shah N. Migraineurs' perceptions of and interactions with pharmacists: a qualitative study. Int J Pharm Pract. 2008;16:357–363
  31. Gupchup GV, Wolfgang AP. A modified work locus of control scale: preliminary investigation of reliability and validity in a sample of pharmacists. Psych Rep. 1997;81:640–642
  32. Schommer JC, Wiederholt JB. Pharmacists' perceptions of patients' needs for counseling. Am J Hosp Pharm. 1994;51:478–485
  33. Latif DA, Berger BA, Harris SG, et al. Relationship between community pharmacists' moral reasoning and components of clinical performance. J Soc Adm Pharm. 1998;15:210–224
  34. Churchill GA. A paradigm for developing better measures of marketing constructs. J Market Res. 1979;16:64–73
  35. Lipton RB, Amatniek JC, Ferrari MD, Gross M. Migraine. Identifying and removing barriers to care. Neurology. 1994;44(6 suppl 4):S63–S68
  36. Venkataraman K, Madhavan S, Bone P. Barriers and facilitators to pharmaceutical care in rural community practice. J Soc Adm Pharm. 1997;14:208–219
  37. Pradel FG, Obeidat NA, Tsoukleris MG. Factors affecting pharmacists' pediatric asthma counseling. J Am Pharm Assoc. 2007;47:737–746
  38. Skomo ML, Desselle SD, Berdine HJ, O'Neil CK. Impact of pharmacist interventions on seeking of medical care by migraineurs. J Am Pharm Assoc. 2008;48:32–37
  39. Berringer R, Shibley M, Cary C, Pugh C, Powers P, Rafi J. Outcomes of a community pharmacy-based diabetes monitoring program. J Am Pharm Assoc. 1999;30:238–243
  40. Cranor CE, Christensen DB. The Asheville Project: short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:149–159
  41. Zillich A, Sutherland J, Kumbera P, Carter B. Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (HOME study). J Gen Intern Med. 2005;20:1091–1096
  42. Osterhaus J, Dedhiya S, Ernst M, Osterhaus M, Mehta SS, Townsend R. Health outcomes assessment in community pharmacy practices: a feasibility project. Arthritis Rheum. 2002;47(2):124–131

PII: S1551-7411(09)00071-0

doi: 10.1016/j.sapharm.2009.05.001

Research in Social and Administrative Pharmacy
Volume 6, Issue 3 , Pages 232-245 , September 2010

Article Tools